Morgan Stanley
MDRX

Morgan Stanley’s Veradigm Inc. Common Stock MDRX Stock Holding History

Morgan Stanley’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,285,948
Closed -$24M – 8063
2023
Q4 		$24M Buy
2,285,948
+1,155,054
+102% +$14.2M ﹤0.01% 3167
2023
Q3 		$14.9M Sell
1,130,894
-3,608
-0.3% -$47.3K ﹤0.01% 2756
2023
Q2 		$14.3M Buy
1,134,502
+170,856
+18% +$2.08M ﹤0.01% 2825
2023
Q1 		$12.6M Sell
963,646
-187,826
-16% -$3.04M ﹤0.01% 2915
2022
Q4 		$20.3M Sell
1,151,472
-357,477
-24% -$5.99M ﹤0.01% 2329
2022
Q3 		$23M Sell
1,508,949
-256,665
-15% -$4.15M ﹤0.01% 2048
2022
Q2 		$26.2M Buy
1,765,614
+940,422
+114% +$17.6M ﹤0.01% 1995
2022
Q1 		$18.6M Buy
825,192
+134,169
+19% +$2.72M ﹤0.01% 2203
2021
Q4 		$12.8M Sell
691,023
-193,360
-22% -$3.07M ﹤0.01% 2661
2021
Q3 		$11.8M Buy
884,383
+204,641
+30% +$3.3M ﹤0.01% 2695
2021
Q2 		$12.6M Sell
679,742
-579,606
-46% -$9.76M ﹤0.01% 2719
2021
Q1 		$18.9M Buy
1,259,348
+630,032
+100% +$10.1M ﹤0.01% 1976
2020
Q4 		$9.09M Sell
629,316
-199,051
-24% -$2.41M ﹤0.01% 2617
2020
Q3 		$6.74M Buy
828,367
+271,129
+49% +$2.22M ﹤0.01% 2420
2020
Q2 		$3.77M Buy
557,238
+415,059
+292% +$2.69M ﹤0.01% 2960
2020
Q1 		$1M Sell
142,179
-212,653
-60% -$1.73M ﹤0.01% 3946
2019
Q4 		$3.48M Buy
354,832
+244,900
+223% +$2.58M ﹤0.01% 3576
2019
Q3 		$1.21M Buy
109,932
+56,984
+108% +$585K ﹤0.01% 4182
2019
Q2 		$616K Sell
52,948
-56,365
-52% -$573K ﹤0.01% 4493
2019
Q1 		$1.04M Sell
109,313
-234,037
-68% -$2.59M ﹤0.01% 4084
2018
Q4 		$3.31M Sell
343,350
-161,254
-32% -$1.8M ﹤0.01% 3337
2018
Q3 		$7.19M Sell
504,604
-1,909,737
-79% -$26M ﹤0.01% 2774
2018
Q2 		$29M Buy
2,414,341
+96,240
+4% +$1.19M 0.01% 1296
2018
Q1 		$28.6M Sell
2,318,101
-400,914
-15% -$5.7M 0.01% 1343
2017
Q4 		$39.6M Buy
2,719,015
+359,030
+15% +$4.99M 0.01% 1106
2017
Q3 		$33.6M Buy
2,359,985
+754,236
+47% +$9.76M 0.01% 1165
2017
Q2 		$20.5M Sell
1,605,749
-92,684
-5% -$1.13M 0.01% 1510
2017
Q1 		$21.5M Sell
1,698,433
-980,134
-37% -$11.6M 0.01% 1486
2016
Q4 		$27.3M Buy
2,678,567
+2,236,933
+507% +$25.5M 0.01% 1268
2016
Q3 		$5.82M Sell
441,634
-1,070,459
-71% -$14.3M ﹤0.01% 2524
2016
Q2 		$19.2M Buy
1,512,093
+616,860
+69% +$8.18M 0.01% 1457
2016
Q1 		$11.8M Buy
895,233
+375,517
+72% +$4.93M ﹤0.01% 1719
2015
Q4 		$7.99M Sell
519,716
-28,679
-5% -$411K ﹤0.01% 2200
2015
Q3 		$6.8M Sell
548,395
-663,080
-55% -$9.13M ﹤0.01% 2359
2015
Q2 		$16.6M Buy
1,211,475
+568,941
+89% +$7.68M 0.01% 1665
2015
Q1 		$7.68M Sell
642,534
-90,359
-12% -$1.1M ﹤0.01% 2335
2014
Q4 		$9.36M Sell
732,893
-406,422
-36% -$5.18M ﹤0.01% 2135
2014
Q3 		$15.3M Buy
1,139,315
+212,256
+23% +$3.22M 0.01% 1651
2014
Q2 		$14.9M Buy
927,059
+116,695
+14% +$1.82M 0.01% 1676
2014
Q1 		$14.6M Buy
810,364
+51,960
+7% +$899K 0.01% 1643
2013
Q4 		$11.7M Buy
758,404
+222,939
+42% +$3.29M 0.01% 1816
2013
Q3 		$7.96M Sell
535,465
-979,643
-65% -$14.8M ﹤0.01% 1976
2013
Q2 		$19.6M Buy
+1,515,108
New +$20.3M 0.01% 1197

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley's MDRX Position: Q1 2024 in Review

Morgan Stanley sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 2,285,948 shares — an estimated $24M sold.

Morgan Stanley first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $39.6M in Q4 2017. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Morgan Stanley reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Morgan Stanley sold 2,285,948 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $24M.
  • Morgan Stanley first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • Morgan Stanley's Veradigm Inc. Common Stock position peaked at $39.6M in Q4 2017.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Morgan Stanley's 13F filing for Q1 2024, filed 15 May 2024.